pharmaglobenews

pharmaglobenews

Non-Cystic Fibrosis Bronchiectasis Market Size is projected to grow at a CAGR of 16.25% by 2034, estimates DelveInsight

DelveInsight’s “Non-Cystic Fibrosis Bronchiectasis Market Insights, Epidemiology, and Market Forecast – 2034” provides a comprehensive analysis of Non-Cystic Fibrosis Bronchiectasis (NCFB), including historical and projected epidemiology, as well as market trends across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom),
29 January 2026

Bioanalytical Testing Services Market Size Expected to Witness Significant Expansion at ~16% CAGR by 2032 | DelveInsight

DelveInsight’s Bioanalytical Testing Services Market Insights Report 2032 provides the current and forecast market analysis, individual leading Bioanalytical Testing Services Companies market shares, challenges, Bioanalytical Testing Services Market Drivers, barriers, trends, and key market Bioanalytical Testing Services companies in the market. Get
29 January 2026

Focal Segmental Glomerulosclerosis Market Size (7MM) was ~USD 734 million in 2022, and It is projected to grow by 2034, estimated DelveInsight

DelveInsight’s “Focal Segmental Glomerulosclerosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Focal Segmental Glomerulosclerosis, historical and forecasted epidemiology and the FSGS market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United
29 January 2026

Cannabinoid Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Cannabinoid Pipeline Insight, 2025” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Cannabinoid pipeline landscape. It covers the Cannabinoid pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cannabinoid pipeline therapeutics assessment by
22 January 2026
1 8 9 10 11 12 14